Cargando…
Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
Genetic variations in individuals may cause differences in the response to cholinesterase inhibitor drugs used in the treatment of Alzheimer’s disease (AD). Through this review, we aimed to understand the potential relationship between genetic polymorphisms and treatment response in AD. We conducted...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445219/ https://www.ncbi.nlm.nih.gov/pubmed/30992661 http://dx.doi.org/10.2147/CIA.S200109 |